Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer shared his take on. Cramer appreciated the company’s research and products during the episode, as he commented: “Even though it’s been a terrible year for healthcare stocks, there are still a handful of real winners like Johnson and Johnson, up more than 24% year to date. I think that’s because of their incredible research work and their remarkable pipeline. It’s differentiating itself from the pack.” Stock market data showing an upward traje ...